Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. New Zealand
  4. New Zealand Stock Exchange
  5. EBOS Group Limited
  6. Summary
    EBO   NZEBOE0001S6

EBOS GROUP LIMITED

(EBO)
  Report
End-of-day quote. End-of-day quote New Zealand Stock Exchange - 01/21
38.15 NZD   -2.43%
01/23EBOS : ASX Appendix 2A
PU
01/17EBOS : Application for quotation of securities - EBO
PU
01/11EBOS to Close $71 Million Retail Offer Next Week
MT
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote New Zealand Stock Exchang…
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
40 40.4 39.98 39.1 38.15 Last
58441 62023 55015 232782 180917 Volume
0.00% +1.00% -1.04% -2.20% -2.43% Change
Estimated financial data (e)
Sales 2022 10 458 M 7 017 M 7 017 M
Net income 2022 240 M 161 M 161 M
Net Debt 2022 712 M 478 M 478 M
P/E ratio 2022 26,9x
Yield 2022 2,52%
Sales 2023 11 187 M 7 506 M 7 506 M
Net income 2023 299 M 201 M 201 M
Net Debt 2023 641 M 430 M 430 M
P/E ratio 2023 24,4x
Yield 2023 2,99%
Capitalization 7 009 M 4 716 M 4 703 M
EV / Sales 2022 0,74x
EV / Sales 2023 0,68x
Nbr of Employees 3 105
Free-Float -
More Financials
Company
Ebos Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care... 
Sector
Drug Retailers
Calendar
02/16Earnings Release
More about the company
Ratings of EBOS Group Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about EBOS GROUP LIMITED
01/23EBOS : ASX Appendix 2A
PU
01/17EBOS : Application for quotation of securities - EBO
PU
01/11EBOS to Close $71 Million Retail Offer Next Week
MT
2021Australia shares close at 3-1/2 month high in post-Christmas trade
RE
2021Australia shares end flat as miners offset gains in tech, health stocks
RE
2021EBOS : Notification regarding unquoted securities - EBO
PU
2021EBOS : Application for quotation of securities - EBO
PU
2021EBOS : Announces Opening of Retail Offer
PU
2021EBOS : Appendix 2A - Placement
PU
2021EBOS Group Completes $458 Million Placement; Shares up 5%
MT
2021EBOS Group Acquiring LifeHealthcare for $837 Million, Raising $459 Million Via Placemen..
MT
2021EBOS : Appendix 3B (Placement and Retail Offer)
PU
2021EBOS : Acquisition of LifeHealthcare and Equity Raising
PU
2021NZ's EBOS to buy LifeHealthcare for $839 mln in Southeast Asia push
RE
2021EBOS : Application for quotation of securities - EBO
PU
More news
News in other languages on EBOS GROUP LIMITED
01/11EBOS clôturera son offre de vente au détail de 71 millions de dollars la semaine procha..
2021Le groupe EBOS réalise un placement de 458 millions de dollars ; les actions augmentent..
2021L'entreprise néo-zélandaise EBOS rachète LifeHealthcare pour 839 millions de dollars da..
2021EBOS Group Limited annonce le versement d'un dividende ordinaire pour le semestre clos ..
2021Le groupe EBOS nomme le PDG de sa division de soins aux animaux ; les actions sont en h..
More news
Chart EBOS GROUP LIMITED
Duration : Period :
EBOS Group Limited Technical Analysis Chart | EBO | NZEBOE0001S6 | MarketScreener
Technical analysis trends EBOS GROUP LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 38,15 NZD
Average target price 37,76 NZD
Spread / Average Target -1,01%
EPS Revisions
Managers and Directors
John Cullity Chief Executive Officer
Leonard Hansen Chief Financial Officer
Elizabeth Mary Coutts Chairman
Andrea Bell Chief Information Officer
Sarah Christine Ottrey Independent Non-Executive Director
Sector and Competitors